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It was found that syphilis-kodecytes used in blood grouping platforms
are capable of the same sensitivity and specificity as validated assays.
The ability to engineer the FSL construct and replace the functional
peptide for other infectious markers allows for a highly flexible and
rapid-development technique for the detection of antibody-defined
infectious markers and may be an important low-technology tool for
use in epidemics and pandemics, particularly in third-world
environments.
The sensitivity of the FSL-SYPH3 kodecytes in the Capture microplate
assay (Method 1) was found to be better than the Capture S method
which uses modified VDRL antigen bound to the microplates (Table1).
FSL-SYPH3 kodecytes, when used in blood typing anti-IgG gel cards
(Method 2), produced good reactions (figure 3) and was found to be
more sensitive than RPR (rapid plasma reagin) and TPHA (treponemal
pallidum hemagglutination assay) syphilis assays and detected 96
of 98 (98%) of EIA+TPPA (enzyme immuno assay + treponemal
pallidum particle agglutination) validated positive samples (Table 2).
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Using a series of algorithms to predict biological activity three
candidate FSL- syphilis constructs were synthesised. Two of
these FSLs showed no biological activity but one, FSL-SYPH3
(figure 1) showed activity against syphilis positive samples.
Two methods based on established microplate and gel
card serological methods were established.
: FSL-SYPH3 kodecytes were
created
Method 1 was
evaluated in parallel with the Capture S method on a
against panels
of validated positive and negative samples. The negative
panel was 32 syphilis serology negative donor plasma
samples. The positive panel was 5 Syphilis Qualification
Panel samples obtained from SeraCare Life Sciences
and confirmed positive using the Olympus PK TP system,
plus 20 Syphilis Validation Panel samples from Plasma
Services Group, Inc. These samples were confirmed
positive using the Arlington Scientific RPR and
EuroimmunTP IgG and IgM ELISA assays.
SYPH3-kodecytes were created as above
except
Serology was in Diamed anti-IgG LISS
gel cards and used as per instructions.
Method 2 was evaluated in parallel
against 98 syphilis-positive clinical
patient samples which were confirmed
as positive by both TPPA & EIA.
Method 1 - FSL-SYP3 Capture
Method 2 - FSL-SYPH3 gelcard:
by incubating 40% packed blood group O red cells
with an equal volume of a solution containing (10µg/ml)
FSL-SYPH3 and incubation overnight at @ 4°C, followed by
washing. Modification was confirmed by flow cytometry
(figure 2). SYPH3-kodecytes were captured onto microplates,
dried and used essentially as described .
Galileo automated blood bank instrument
incubation was for 2 hours @ 37°C.
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Materials & Methods
The ability to detect infectious agents is a prerequisite to the treatment
and containment of transmittable diseases. Many diagnostics assays are
based upon the detection of antibodies in serum against the infectious
agent and often rely on ELISA or agglutination-based assays to determine
the infectious status. Using function-spacer-lipid (FSL) constructs
bearing peptides representative of an infectious agent attached to
human red cells, offers a potential alternative diagnostic approach to the
detection of antibody-defined infections. Using the syphilis spirochaete
as a model, and a peptide selection algorithm, a series of FSL constructs
were created and attached to human red cells creating
syphilis-kodecytes. These kodecytes were then tested in routine blood
typing platforms against serum from panels and blood donors of known
syphilis status. This approach has already been successfully used to
detect ethnic-specific blood group antibodies .
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FSL constructs are analogous in structure to a flower and consist of three
components; a unctional head group (like the flower head), a pacer
(like a stalk) and a diacyl ipid tail (the anchoring roots). All FSLs are
biocompatible and allow users to introduce novel unctional moieties
to the membrane surface of living cells.
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Figure 1. FSL-SYPH3
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Table 2. FSL-SYPH3 gelcard Method 2
comparison with TPHA and RPR
of 98 EIA+TPPA positive samples
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Table 1. Comparison of Capture S method
with new FSL-SYPH3 Capture method 1
Figure 2. Flow cytometry
of FSL-SYPH3 kodecytes.
Grey = positive serum
Green = negative serum
Figure 3. Examples of
FSL-SYPH3 kodecyte
gelcard reactions
Strong Medium Weak Negative
